(VIANEWS) - Mosaic Company (MOS), Sonic Automotive (SAH), Regeneron Pharmaceuticals (REGN) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Mosaic Company (MOS)
72% sales growth and 15.95% return on equity
The Mosaic Company, through its subsidiaries, produces and markets concentrated phosphate and potash crop nutrients in North America and internationally.
Mosaic Company's sales growth this year is anticipated to be 42.3% and 23.2% for next year.
Year-on-year quarterly revenue growth grew by 56.3%, now sitting on 12.36B for the twelve trailing months.
Volume
Today's last reported volume for Mosaic Company is 9590160 which is 84.16% above its average volume of 5207440.
Mosaic Company's sales growth for the next quarter is 72%. The company's growth estimates for the current quarter and the next is 249.1% and 282.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.95%.
Volatility
Mosaic Company's last day, last week, and last month's current intraday variation average was 2.29%, 1.71%, and 2.17%, respectively.
Mosaic Company's highest amplitude of average volatility was 8.15% (day), 4.35% (last week), and 5.03% (last month), respectively.
Mosaic Company's Stock Yearly Top and Bottom Value
Mosaic Company's stock is valued at $45.20 at 19:22 EST, below its 52-week high of $47.55 and way above its 52-week low of $28.05.
Mosaic Company's Moving Average
Mosaic Company's worth is way higher than its 50-day moving average of $41.01 and way higher than its 200-day moving average of $36.24.2. Sonic Automotive (SAH)
25.2% sales growth and 38.33% return on equity
Sonic Automotive, Inc. operates as an automotive retailer in the United States.
Sonic Automotive's sales growth this year is expected to be 36.2% and 8.8% for next year.
Year-on-year quarterly revenue growth grew by 13.8%, now sitting on 12.4B for the twelve trailing months.
Volume
Today's last reported volume for Sonic Automotive is 318297 which is 2.33% above its average volume of 311022.
Sonic Automotive's sales growth for the next quarter is 25.2%. The company's growth estimates for the current quarter and the next is 75.6% and negative -4.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 38.33%.
Volatility
Sonic Automotive's last day, last week, and last month's current intraday variation average was 2.25%, 1.84%, and 1.98%, respectively.
Sonic Automotive's highest amplitude of average volatility was 6.43% (day), 4.95% (last week), and 3.92% (last month), respectively.
Sonic Automotive's Stock Yearly Top and Bottom Value
Sonic Automotive's stock is valued at $51.79 at 19:22 EST, way under its 52-week high of $58.00 and way higher than its 52-week low of $42.33.
Sonic Automotive's Moving Average
Sonic Automotive's value is higher than its 50-day moving average of $49.10 and above its 200-day moving average of $49.64.3. Regeneron Pharmaceuticals (REGN)
18.3% sales growth and 51.09% return on equity
Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide.
Regeneron Pharmaceuticals's sales growth this year is expected to be 56.3% and a negative 10.8% for next year.
Year-on-year quarterly revenue growth grew by 50.5%, now sitting on 13.36B for the twelve trailing months.
Volume
Today's last reported volume for Regeneron Pharmaceuticals is 484375 which is 37.69% below its average volume of 777414.
Regeneron Pharmaceuticals's sales growth for the next quarter is 18.3%. The company's growth estimates for the present quarter and the next is 7.7% and 8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 51.09%.
Volatility
Regeneron Pharmaceuticals's last day, last week, and last month's current intraday variation average was 0.05%, 0.94%, and 1.13%, respectively.
Regeneron Pharmaceuticals's highest amplitude of average volatility was 2.03% (day), 2.53% (last week), and 2.65% (last month), respectively.
Regeneron Pharmaceuticals's Stock Yearly Top and Bottom Value
Regeneron Pharmaceuticals's stock is valued at $618.36 at 19:22 EST, below its 52-week high of $686.62 and way above its 52-week low of $441.00.
Regeneron Pharmaceuticals's Moving Average
Regeneron Pharmaceuticals's value is higher than its 50-day moving average of $610.79 and higher than its 200-day moving average of $567.66.Previous days news about Regeneron Pharmaceuticals(REGN)
- According to Bloomberg Quint on Monday, 28 February, "Intellia Therapeutics Inc. and Regeneron Pharmaceuticals Inc.'s experimental gene-editing therapy cut levels of an abnormal liver protein in interim, early-stage trial results, a step toward showing Crispr technology can provide lasting treatment."
4. Transcat (TRNS)
17.9% sales growth and 14.85% return on equity
Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally.
Transcat's sales growth this year is expected to be 17.8% and 8.1% for next year.
Year-on-year quarterly revenue growth grew by 15.5%, now sitting on 197.84M for the twelve trailing months.
Volume
Today's last reported volume for Transcat is 38205 which is 18.4% below its average volume of 46820.
Transcat's sales growth for the next quarter is 17.9%. The company's growth estimates for the present quarter and the next is 7.1% and negative -24.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.85%.
Volatility
Transcat's last day, last week, and last month's current intraday variation average was 2.51%, 2.85%, and 2.73%, respectively.
Transcat's highest amplitude of average volatility was 4.44% (day), 4.50% (last week), and 4.96% (last month), respectively.
Transcat's Stock Yearly Top and Bottom Value
Transcat's stock is valued at $73.71 at 19:22 EST, way below its 52-week high of $101.05 and way above its 52-week low of $42.12.